Hanson Wade is a leading provider of content-led conferences and data products within specialized and high-growth niches in the life sciences industry. The company holds more than 100 conferences per year catering to more than 7,500 delegates and over 580 sponsors.
“Hanson Wade has a strong reputation in the market for providing high-quality, premium conferences. We believe that by providing financing for this transaction, the company will continue its strong historic growth in the stable, non-cyclical life sciences market,” said Christine Vanden Beukel, managing director and head of Crescent’s European Specialty Lending strategy.
“This is the second transaction we have worked on with Graphite in the broader life sciences space having financed its acquisition of Random42 in July 2017. We look forward to continuing to provide the types of flexible capital that sponsors and companies need to grow their businesses.”
Crescent Capital Group is headquartered in Los Angeles with offices in Boston, London, and New York.